These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36312273)

  • 21. Systemic Thrombolysis Versus Device Exchange for Pump Thrombosis Management: A Single-Center Experience.
    Oezpeker C; Zittermann A; Ensminger S; Kizner L; Koster A; Sayin A; Schoenbrodt M; Milting H; Gummert JF; Morshuis M
    ASAIO J; 2016; 62(3):246-51. PubMed ID: 26771393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dying With a Left Ventricular Assist Device as Destination Therapy.
    Dunlay SM; Strand JJ; Wordingham SE; Stulak JM; Luckhardt AJ; Swetz KM
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of patients supported with the HeartWare left ventricular assist system.
    Al Masri E; Al Shakaki M; Welp H; Scherer M; Dell'Aquila AM
    Artif Organs; 2020 Oct; 44(10):1061-1066. PubMed ID: 32216106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left Ventricular Assist Device Inflow Cannula Position May Contribute to the Development of HeartMate II Left Ventricular Assist Device Pump Thrombosis.
    Bhama JK; Bansal A
    Ochsner J; 2018; 18(2):131-135. PubMed ID: 30258293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral protection during percutaneous intervention for left ventricular assist device outflow graft obstruction.
    Joury A; Patel RAG; Wever-Pinzon J; Eiswirth C; Desai S; Bansal A; Krim SR
    Catheter Cardiovasc Interv; 2022 Aug; 100(2):266-273. PubMed ID: 35612519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
    N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
    Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
    J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA
    J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy.
    Pedde D; Soltani S; Stein J; Tsyganenko D; Müller M; Schönrath F; Falk V; Potapov EV
    Eur J Cardiothorac Surg; 2020 Feb; 57(2):325-330. PubMed ID: 31317177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty.
    Gyoten T; Rojas SV; Fox H; Hata M; Deutsch MA; Schramm R; Gummert JF; Morshuis M
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):855-862. PubMed ID: 33367693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First series of left ventricular assist device exchanges to HeartMate 3.
    Hanke JS; Rojas SV; Dogan G; Feldmann C; Beckmann E; Deniz E; Wiegmann B; Michaelis JE; Napp LC; Berliner D; Shrestha M; Bauersachs J; Haverich A; Schmitto JD
    Eur J Cardiothorac Surg; 2017 May; 51(5):887-892. PubMed ID: 28329060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices.
    Tsiouris A; Paone G; Nemeh HW; Borgi J; Williams CT; Lanfear DE; Morgan JA
    World J Cardiol; 2015 Nov; 7(11):792-800. PubMed ID: 26635927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing in-hospital cardiovascular, thrombotic and bleeding outcomes in patients with chronic liver disease undergoing left ventricular assist device implantation.
    Grant JK; Ebner B; Vincent L; Maning J; Olorunfemi O; Olarte NI; Colombo R; Munagala M; Chaparro S
    Thromb Res; 2021 Jun; 202():184-190. PubMed ID: 33892219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical Management of Recurrent Left Ventricular Assist Device Thrombosis in a Patient With Biventricular Assist Devices.
    Onderko L; Novak SH; Francis SA; Shao ES; Afari M
    Cureus; 2020 Dec; 12(12):e11872. PubMed ID: 33409104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus.
    Hanke JS; Rojas SV; Cvitkovic T; Wiegmann B; Horke A; Warnecke G; Haverich A; Schmitto JD
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):503-508. PubMed ID: 28962493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation.
    Kato TS; Colombo PC; Nahumi N; Kitada S; Takayama H; Naka Y; Di Tullio MR; Homma S; Mancini D; Jorde UP; Uriel N
    Echocardiography; 2014; 31(1):E5-9. PubMed ID: 24063315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.